Topic Hub
4 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 4 of 4 clinical reviews.
Evidence-based adverse-event management protocols for BPC-157 and TB-500 healing peptides, including grading scales, clinical decision points, dose modifications, and when to discontinue therapy.
Read clinical reviewEvidence-based monitoring protocol for BPC-157 and TB-500 peptide therapy. Lab panels, timing, safety signals, and clinical decision points for prescribers managing tissue-repair peptides.
Read clinical reviewEvidence-based special-populations guide for BPC-157 and TB-500 (thymosin beta-4). Covers renal impairment, hepatic dysfunction, pediatrics, geriatrics, pregnancy, lactation, and immunocompromised patients at MD/PharmD level.
Read clinical reviewA prescriber-level guide to billing, coding, prior authorization, and regulatory compliance for BPC-157 and TB-500 healing peptides, including compounding pharmacy workflows and cash-pay models.
Read clinical review